Two complementary pilot projects will serve as vital foundation work for the implementation of Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs) across MPCCC [...]

Latrobe Regional Hospital (LRH) is in the process of activating its first ever oncology clinical trial, thanks to the MPCCC's Monash-Gippsland Teletrials (MGTT) project. The [...]

Since its commencement in September 2018, the MPCCC Precision Oncology Program has established regular Molecular Tumour Board meetings that focus on three distinct tumour streams. [...]

As MPCCC’s pilot of shared-care for cancer related depression approaches completion, participants will be invited to evaluate the feasibility of the model and its potential [...]

Outcomes of the Australian-led landmark clinical trial, ENZAMET, are expected to influence clinical practice around the world for men with advanced metastatic prostate cancer. The [...]

Research projects have the potential to improve health services and outcomes for patients, but effectively engaging consumers and the community can enhance research and translation [...]

Professor Melissa Southey has been appointed as the Research Director of the Monash Partners Comprehensive Cancer Consortium (MPCCC) following the resignation of Prof Gail Risbridger [...]

Over two million cancer patients per year may be saved from life-threatening Invasive Fungal Infections (IFI) with the aid of artificial intelligence that supports diagnosis [...]

Prof David Thomas, Director of the Kinghorn Cancer Centre, Founder of the Australian Cancer Genomics Medicine Programme, and arguably Australia’s leader in precision oncology, captivated [...]

After over nine years dedicated to developing collaborative cancer research platforms across Monash University, Prof Gail Risbridger this month announced her resignation from the role [...]